Clover Biopharmaceuticals Revenue

In the year 2025, Clover Biopharmaceuticals had annual revenue of 3.51M CNY, down -90.88%. Clover Biopharmaceuticals had revenue of 251.00K in the half year ending December 31, 2025, a decrease of -99.36%.

Revenue

3.51M CNY

Revenue Growth

-90.88%

P/S Ratio

988.40

Revenue / Employee

14.42K CNY

Employees

243

Market Cap

3.86B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.51M	-34.91M	-90.88%
Dec 31, 2024	38.42M	-836.00K	-2.13%
Dec 31, 2023	39.26M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
TYK Medicines	117.25K
Qyuns Therapeutics	897.99M
BioDlink International Company	831.99M
Mirxes Holding Company	166.32M
Viva Biotech Holdings	1.92B
Shandong Boan Biotechnology	873.36M
Antengene Corporation	117.22M
Jiangsu Recbio Technology	14.16M

Revenue Rankings

Clover Biopharmaceuticals News

5 weeks ago - Clover Biopharmaceuticals Reports Positive U.S. Phase I Data On RSV Re-Vaccination In Older Adults - Nasdaq

More News